- Research & Development
- About us
- Invest in us
- Malaria & medicines
Malaria & medicines
- kills ~584,000 people each year – the vast majority are children
- can kill within 24 hours of symptom onset
- costs Africa USD 12 billion in lost GDP every year
- accounts for 40% of all public health spending in Africa
- is both a cause and consequence of poverty
ACTs are currently recommended as first-line treatment for uncomplicated P.falciparum malaria by the WHO. Discover how the treatment of malaria has progressed over the ages.
It takes 13-15 years to discover and develop a new antimalarial. This graphic takes you through the steps involved in this complex process.
MMV and the WHO joined forces to harmonise the production of artemisinin. See how these efforts helped to ensure sufficient supply of artemisinin for ACT needs.
There are five species of protozoan parasites of the genus Plasmodium that have been known to cause human malaria. Learn about the key differences between the species.
As the malaria parasites enter the blood stream they infect and destroy red blood cells. See what symptoms may result and learn the difference between uncomplicated and severe malaria.
Defeating malaria requires a comprehensive approach. Find out why both prevention and treatment are needed and why no one tool alone can defeat the parasite.